Table 1.
Characteristics of the included subjects
| Characteristics | All | Control | DOR | PCOS | P | |
|---|---|---|---|---|---|---|
| Cases (N) | 2117 | 1714 | 335 | 68 | ||
| Age (years) | 32.02 ± 6.80 | 30.51 ± 5.54 | 40.67 ± 6.55 | 27.71 ± 3.43 | < 0.001 | |
| Weight (kg) | 54.34 ± 8.01 | 53.83 ± 7.99 | 56.06 ± 7.39 | 58.83 ± 9.14 | < 0.001 | |
| Height (cm) | 160.90 ± 4,81 | 160.94 ± 4.85 | 160.62 ± 4.65 | 161.22 ± 4.60 | 0.455 | |
| BMI (kg/m2) | 20.98 ± 2,86 | 20.77 ± 2.84 | 21.72 ± 2.63 | 22.60 ± 3.19 | < 0.001 | |
| AMH (ng/ml) | 3.48 ± 3.09 | 4.08 ± 3.00 | 0.29 ± 0.22 | 6.93 ± 3.84 | < 0.001 | |
| FPG (mmol/L) | 5.01 ± 0.29 | 5.02 ± 0.30 | 4.99 ± 0.28 | 4.97 ± 0.28 | 0.288 | |
| FPI (pmol/L) | 90.28 ± 66.66 | 91.31 ± 67.48 | 75.80 ± 55.39 | 96.14 ± 54.34 | 0.565 |
Data were presented as mean ± SD
DOR Decreased ovarian reserve. AMH Anti-Müllerian hormone. PCOS Polycystic ovarian syndrome. BMI Body mass index. FPG Fasting plasma glucose. FPI Fasting plasma insulin